Block listing Interim Review

Summary by AI BETAClose X

Hikma Pharmaceuticals PLC reports the six-monthly return for its block listing as of October 1, 2025. The report pertains to the Hikma Pharmaceuticals PLC 2018 Management Incentive Plan and the 2014 Executive Incentive Plan. The period covered is from April 1, 2025, to September 30, 2025. The balance of unallotted securities under the schemes from the previous return was 311,430 ordinary shares of 10 pence. The block scheme has not been increased since the last return, with an increase of 0 ordinary shares of 10 pence. During the period, 0 ordinary shares of 10 pence were issued or allotted under the schemes. Consequently, the balance under the schemes not yet issued or allotted at the end of the period remains at 311,430 ordinary shares of 10 pence.

Disclaimer*

Companies

Hikma Pharmaceuticals (HIK)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today